26 research outputs found
Recommended from our members
Consumption of fish oil providing amounts of eicosapentaenoic acid and docosahexaenoic acid that can be obtained from the diet reduces blood pressure in adults with systolic hypertension: a retrospective analysis
Background: Although a large number of randomized controlled trials (RCTs) have examined the impact of the n-3 (ω-3) fatty acids EPA (20:5n-3) and DHA (22:6n-3) on blood pressure and vascular function, the majority have used doses of EPA+DHA of > 3 g per d,which are unlikely to be achieved by diet manipulation.
Objective: The objective was to examine, using a retrospective analysis from a multi-center
RCT, the impact of recommended, dietary achievable EPA+DHA intakes on systolic and diastolic blood pressure and microvascular function in UK adults.
Design: Healthy men and women (n = 312) completed a double-blind, placebo-controlled RCT consuming control oil, or fish oil providing 0.7 g or 1.8 g EPA+DHA per d in random order each for 8 wk. Fasting blood pressure and microvascular function (using Laser Doppler Iontophoresis) were assessed and plasma collected for the quantification of markers of vascular function. Participants were retrospectively genotyped for the eNOS rs1799983 variant.
Results: No impact of n-3 fatty acid treatment or any treatment * eNOS genotype interactions were evident in the group as a whole for any of the clinical or biochemical outcomes. Assessment of response according to hypertension status at baseline indicated a significant (P=0.046) fish oil-induced reduction (mean 5 mmHg) in systolic blood pressure specifically in those with isolated systolic hypertension (n=31). No dose response was observed.
Conclusions: These findings indicate that, in those with isolated systolic hypertension, daily doses of EPA+DHA as low as 0.7 g bring about clinically meaningful blood pressure reductions which, at a population level, would be associated with lower cardiovascular disease risk. Confirmation of findings in an RCT where participants are prospectively recruited on the basis of blood pressure status is required to draw definite conclusions
Recommended from our members
Diversity of Neuropeptide Cell-Cell Signaling Molecules Generated by Proteolytic Processing Revealed by Neuropeptidomics Mass Spectrometry.
Neuropeptides are short peptides in the range of 3-40 residues that are secreted for cell-cell communication in neuroendocrine systems. In the nervous system, neuropeptides comprise the largest group of neurotransmitters. In the endocrine system, neuropeptides function as peptide hormones to coordinate intercellular signaling among target physiological systems. The diversity of neuropeptide functions is defined by their distinct primary sequences, peptide lengths, proteolytic processing of pro-neuropeptide precursors, and covalent modifications. Global, untargeted neuropeptidomics mass spectrometry is advantageous for defining the structural features of the thousands to tens of thousands of neuropeptides present in biological systems. Defining neuropeptide structures is the basis for defining the proteolytic processing pathways that convert pro-neuropeptides into active peptides. Neuropeptidomics has revealed that processing of pro-neuropeptides occurs at paired basic residues sites, and at non-basic residue sites. Processing results in neuropeptides with known functions and generates novel peptides representing intervening peptide domains flanked by dibasic residue processing sites, identified by neuropeptidomics. While very short peptide products of 2-4 residues are predicted from pro-neuropeptide dibasic processing sites, such peptides have not been readily identified; therefore, it will be logical to utilize metabolomics to identify very short peptides with neuropeptidomics in future studies. Proteolytic processing is accompanied by covalent post-translational modifications (PTMs) of neuropeptides comprising C-terminal amidation, N-terminal pyroglutamate, disulfide bonds, phosphorylation, sulfation, acetylation, glycosylation, and others. Neuropeptidomics can define PTM features of neuropeptides. In summary, neuropeptidomics for untargeted, global analyses of neuropeptides is essential for elucidation of proteases that generate diverse neuropeptides for cell-cell signaling. Graphical Abstract ᅟ
Multiple gas-phase conformations of proline-containing peptides: is it always cis/trans isomerization?
Ion mobility-mass spectrometry (IM-MS) is often employed to look at the secondary, tertiary, and quaternary structures of naked peptides and proteins in the gas-phase. Recently, it has offered a unique glimpse into proline-containing peptides and their cis/trans Xxx-Pro isomers. An experimental "signature" has been identified wherein a proline-containing peptide has its Pro residues substituted with another amino acid and the presence or absence of conformations in the IM-MS spectra is observed. Despite the high probability that one could attribute these conformations to cis/trans isomers, it is also possible that cis/trans isomers are not the cause of the additional conformations in proline-containing peptides. However, the experimental evidence of such a system has not been demonstrated or reported. Herein, we present the IM-MS analysis of Neuropeptide Y's wild-type (WT) signal sequence and Leu7Pro (L7P) mutant. Although comparison of arrival times and collision cross-sections of [M + 4H](4+) ions yields the cis/trans "signature", molecular dynamics indicates that a cis-Pro7 is not very stable and that trans-Pro7 conformations of the same cross-section arise with equal frequency. We believe that this work further underscores the importance of theoretical calculations in IM-MS structural assignments.11Nsciescopu
Recommended from our members
Phosphopeptidomics Reveals Differential Phosphorylation States and Novel SxE Phosphosite Motifs of Neuropeptides in Dense Core Secretory Vesicles
Neuropeptides are vital for cell-cell communication and function in the regulation of the nervous and endocrine systems. They are generated by post-translational modification (PTM) steps resulting in small active peptides generated from prohormone precursors. Phosphorylation is a significant PTM for the bioactivity of neuropeptides. From the known diversity of distinct neuropeptide functions, it is hypothesized that the extent of phosphorylation varies among different neuropeptides. To assess this hypothesis, neuropeptide-containing dense core secretory vesicles from bovine adrenal medullary chromaffin cells were subjected to global phosphopeptidomics analyses by liquid chromatography (LC)-mass spectrometry (MS/MS). Phosphopeptides were identified directly by LC-MS/MS and indirectly by phosphatase treatment followed by LC-MS/MS. The data identified numerous phosphorylated peptides derived from neuropeptide precursors such as chromogranins, secretogranins, proenkephalin and pro-NPY. Phosphosite occupancies were observed at high and low levels among identified peptides and many of the high occupancy phosphopeptides represent prohormone-derived peptides with currently unknown bioactivities. Peptide sequence analyses demonstrated SxE as the most prevalent phosphorylation site motif, corresponding to phosphorylation sites of the Fam20C protein kinase known to be present in the secretory pathway. The range of high to low phosphosite occupancies for neuropeptides demonstrates cellular regulation of neuropeptide phosphorylation. Graphical Abstract ᅟ
Site-Specific Characterization of d‑Amino Acid Containing Peptide Epimers by Ion Mobility Spectrometry
Traditionally, the d-amino
acid containing peptide (DAACP) candidate can be discovered by observing
the differences of biological activity and chromatographic retention
time between the synthetic peptides and naturally occurring peptides.
However, it is difficult to determine the exact position of d-amino acid in the DAACP candidates. Herein, we developed a novel
site-specific strategy to rapidly and precisely localize d-amino acids in peptides by ion mobility spectrometry (IMS) analysis
of mass spectrometry (MS)-generated epimeric fragment ions. Briefly,
the d/l-peptide epimers were separated by online
reversed-phase liquid chromatography and fragmented by collision-induced
dissociation (CID), followed by IMS analysis. The epimeric fragment
ions resulting from d/l-peptide epimers exhibit
conformational differences, thus showing different mobilities in IMS.
The arrival time shift between the epimeric fragment ions was used
as criteria to localize the d-amino acid substitution. The
utility of this strategy was demonstrated by analysis of peptide epimers
with different molecular sizes, [d-Trp]-melanocyte-stimulating
hormone, [d-Ala]-deltorphin, [d-Phe]-achatin-I,
and their counterparts that contain all-l amino acids. Furthermore,
the crustacean hyperglycemia hormones (CHHs, 8.5 kDa) were isolated
from the American lobster Homarus americanus and identified by integration of MS-based bottom-up and top-down
sequencing approaches. The
IMS data acquired using our novel site-specific strategy localized
the site of isomerization of l- to d-Phe at the
third residue of the CHHs from the N-terminus. Collectively, this
study demonstrates a new method for discovery of DAACPs using IMS
technique with the ability to localize d-amino acid residues
Evaluation and Application of Dimethylated Amino Acids as Isobaric Tags for Quantitative Proteomics of the TGF-β/Smad3 Signaling Pathway
Isobaric
labeling has become a widespread tool for quantitative
proteomic studies. Here, we report the development and evaluation
of several dimethylated amino acids as novel isobaric tags for quantitative
proteomics. Four-plex dimethylated alanine (DiAla), valine (DiVal),
and leucine (DiLeu) have been synthesized, sharing common features
of peptide tagging and reporter ion production. DiAla and DiLeu are
shown to achieve complete labeling. These two tags’ impacts
on peptide fragmentation and quantitation are further evaluated using
HEK293 cell lysate. DiAla labeling generates more abundant backbone
fragmentation whereas DiLeu labeling produces more intense reporter
ions. Nonetheless, both tags enable accurate quantitative analysis
of HEK293 cell proteomes. DiAla and DiLeu tags are then applied to
study the TGF-β/Smad3 pathway with four differentially treated
mouse vascular smooth muscle (MOVAS) cells. Our MS data reveal proteome-wide
changes of AdSmad3 as compared to the GFP control, consistent with
previous findings of causing smooth muscle cell (SMC) dedifferentiation. Additionally, the other two novel mutations on
the hub protein Smad3, Y226A, and D408H, show compromised TGF-β/Smad3-dependent
gene transcription and reversed phenotypic switch. These results are
further corroborated with Western blotting and demonstrate that the
novel DiAla and DiLeu isobaric tagging reagents provide useful tools
for multiplex quantitative proteomics
Recommended from our members
A Commensal Dipeptidyl Aminopeptidase with Specificity for N‑Terminal Glycine Degrades Human-Produced Antimicrobial Peptides in Vitro
Proteases within the C1B hydrolase family are encoded by many organisms. We subjected a putative C1B-like cysteine protease secreted by the human gut commensal Parabacteroides distasonis to mass spectrometry-based substrate profiling to find preferred peptide substrates. The P. distasonis protease, which we termed Pd_dinase, has a sequential diaminopeptidase activity with strong specificity for N-terminal glycine residues. Using the substrate sequence information, we verified the importance of the P2 glycine residue with a panel of fluorogenic substrates and calculated kcat and KM for the dipeptide glycine-arginine-AMC. A potent and irreversible dipeptide inhibitor with a C-terminal acyloxymethyl ketone warhead, glycine-arginine- AOMK, was then synthesized and demonstrated that the Pd_dinase active site requires a free N-terminal amine for potent and rapid inhibition. We next determined the homohexameric Pd_dinase structure in complex with glycine-arginine- AOMK and uncovered unexpected active site features that govern the strict substrate preferences and differentiate this protease from members of the C1B and broader papain-like C1 protease families. We finally showed that Pd_dinase hydrolyzes several human antimicrobial peptides and therefore posit that this P. distasonis enzyme may be secreted into the extracellular milieu to assist in gut colonization by inactivation of host antimicrobial peptides